Drug discovery in Big Pharma is dying. - Recensione dipendente - Principal Scientist presso Pfizer

2,0
14 mag 2010
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Very good pay and benefits

Svantaggi

Too much bureacracy, not enough science driven decisons. Management is overly concerned with late stage projects so that the early stage projects have suffered. Managers are engaged to gather inforamtion and feed it upwards. There is very little communication flowing down to bench scientists.

Esplora altre recensioni su Pfizer

5,0
12 giu 2026
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Good life balance, good compensation

Svantaggi

Instability, upper leadership often decides to change direction.

2,0
3 giu 2026
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

A good amount of remote monitoring, which depending on how you view can be a positive.

Svantaggi

Changing systems and inconsistent standards are applied to people. There are many differing models that often muddy how you are supposed to do your job, especially when other staff members don't quite understand. How do you interface with the changing models? There tends to be a lot of blame and foisting of responsibilities. Sometimes you can become overburdened with a lot of work, where people do not respect your time and think that their tasks should take priority. It is possible to be contacted late at night with work to do and then be criticized the next day for not being able to keep up.

1
Vedi recensioni per: Utile|Valutazione|Data|Tutto